Bio Sequence

Easily Obtain Gene Sequences by Using Gene Names in The Patsnap Bio Database

29 August 2023
3 min read

Acquiring the sequence of a gene founded on its title is feasible and this article introduces one uncomplicated and swift technique that is consistently utilized. The Patsnap Bio Database endorses an array of retrieval methodologies encompassing general sequences, motif sequences, antibody sequences (CDRs), fragment sequences, combination sequences, and drug-gene sequences. Crucially, it furnishes provisions for gene name inquiries. Kindly follow this link for gratuitous access to the Patsnap Bio Sequence Database

Described below are the steps for the search process: Primarily, accede to the Patsnap Bio Database and click on "Drug/Gene Search" on the left sidebar. Subsequently, input the gene name within the search box where a dropdown menu will suggest various gene names. From these suggestions, pinpoint and choose the desired gene. Click on the "Search" button to commence the search.

图形用户界面, 应用程序

描述已自动生成

Secondarily, following the receipt of the search outcomes from the Patsnap Bio Database, it is possible to employ further filters to fine-tune the results. These filters may comprise sequence length, sequence type (DNA or protein), and specific species; eventually enabling the identification of the most pertinent sequences. Data outcomes support the exportation of FASTA files and the saving of sequences. Further, there are alternatives available to investigate public sources for additional data.

图形用户界面, 文本, 应用程序, Word, 电子邮件

描述已自动生成

Thirdly, the search outcomes are also linked to the patent database providing direct access to patent specifics.

图形用户界面, 文本, 应用程序

描述已自动生成

It is important to note that Patsnap Bio is the most extensive sequence search platform for the Patsnap database. It incorporates AI with human-curated data for comprehensive handling of protein and nucleotide sequence data plucked from global patents, biological periodicals, and public repositories. Essential biological sequences are manually annotated illuminating structural modifications to provide the most accurate sequence data and boost sequence retrieval efficiency.

Free registration is currently available to utilize the Bio biological sequence database: https://bio-patsnap-com.libproxy1.nus.edu.sg. Act now to expedite your gene sequence search tasks.

How does AstraZeneca's PARP inhibitor differentiate?
Valuable Targets
10 min read
How does AstraZeneca's PARP inhibitor differentiate?
28 August 2023
PARP inhibitors had once brought about a "decade breakthrough" for ovarian cancer, and in search for new areas of business growth, AZ is primarily seeking the approval for the use of olaparib in metastatic prostate cancer.
Read →
The world's first Maternal Vaccine! Analysis of Pfizer's RSV Vaccine
Drug Insights
3 min read
The world's first Maternal Vaccine! Analysis of Pfizer's RSV Vaccine
25 August 2023
This is the first and only RSV vaccine for pregnant women, marking an important milestone for public health.
Read →
Sales fall short of expectations, how can KRAS G12C be differentiated in R&D?
Valuable Targets
10 min read
Sales fall short of expectations, how can KRAS G12C be differentiated in R&D?
25 August 2023
With KRAS, a previously considered untouchable target, being cracked open, the KRAS G12C inhibitors of Amgen and Mirati are now on the market. The question is, how can we further optimize treatment outcomes for patients?
Read →
Can Arvinas lead the treatment of neurodegenerative diseases?
Advanced Tech.
8 min read
Can Arvinas lead the treatment of neurodegenerative diseases?
25 August 2023
Arvinas is currently conducting preclinical studies on protein degradation for neurodegenerative diseases.
Read →
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.